Kraig Labs Converts Record Silk Cocoon Production, Advances Commercialization

  • Kraig Biocraft Laboratories produced approximately 1.8 metric tons of recombinant spider silk cocoons earlier this month.
  • The company reports that conversion of these cocoons into reeled silk fiber is currently 50% complete.
  • This represents the largest volume of recombinant spider silk ever processed by Kraig Labs.
  • Kim Thompson, Founder and CEO, stated the progress aligns with the company’s broader production strategy.

Kraig Biocraft Laboratories' progress in converting cocoons to reeled silk represents a critical step towards commercializing spider silk, a material with potential applications across textiles, medical devices, and advanced composites. While the company's National Geographic feature highlights growing interest in biomaterials, the ability to consistently and affordably produce and process spider silk remains a significant hurdle for widespread adoption. The current milestone demonstrates progress, but scalability and cost remain key factors determining long-term success.

Production Efficiency
The remaining 50% conversion rate will be a key indicator of Kraig Labs’ ability to scale its processing capabilities and maintain cost-effectiveness as production volumes increase.
Market Adoption
The availability of a substantial inventory of reeled silk fiber will test the demand for spider silk in various applications, particularly given the premium pricing associated with this novel material.
Competitive Landscape
The company's claim of being the 'only reliable, commercially scalable, and cost-effective supply chain' will be challenged as other players potentially enter the recombinant spider silk market.